COVID-19 Vaccines

The FDA reversed course and said it had become clear it needed to wait for data on how well that third shot works for this age group.

On Tuesday, the Health Resources and Services Administration is distributing $66.5 million to community groups working in 38 states and in Washington, D.C.

The governor says people need to protect themselves with the mask mandate for businesses ending Friday, and for schools on April 1.

Citing recent data from the CDC, officials in the Garden State will use all of their outreach strategies to promote boosters.

The first big hurdle was crossed when Pfizer shared its clinical trial data with the FDA. There are five more steps before this vulnerable population can be vaxxed.

The move could open the way for the very youngest Americans to start receiving shots by early March.

The FDA is pushing the company to submit its application based on the two-dose data for potential approval in February.

Full approval means FDA has completed the same rigorous, time-consuming review for Moderna’s shot as dozens of other long-established vaccines.

The mandate is first taking effect first in jurisdictions that didn’t challenge the requirement in court.

The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer began a similar study of its own reformulated shots.

COVID-19 vaccine makers have been updating their shots to better match omicron in case global health authorities decide the change is needed.

City health officials announced earlier this year they had given out more than 260,000 booster doses since August. This is how the numbers break down.

Philadelphia Mayor Jim Kenney has indefinitely postponed the vaccine mandate for the city’s unionized employees.

Three new U.S. studies offer more evidence that the COVID-19 vaccines are standing up to the omicron variant, at least among people who have gotten booster shots.

Now researchers in the U.K. have the first estimates for how long a third shot of the Pfizer vaccine will last. The findings are mixed.